ArticleMolecular oncology2023
Engaging European society at the forefront of cancer research and care: How discussions at the 5
Article in Molecular oncology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed.
- European cancer research requires renewed urgency.Nature cancer · 2025Article
- From the creation of the European research area in 2000 to a Mission on cancer in Europe in 2021-lessons learned and implications.Molecular oncology · 2024Article
- Demographic Analysis of Cancer Research Priorities and Treatment Correlations.Current oncology (Toronto, Ont.) · 2024Article
- Article
- UNCAN.eu: Toward a European Federated Cancer Research Data Hub.Cancer discovery · 2024Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
30 authors.
Funding
Abstract
European cancer research stakeholders met in October 2022 in Heidelberg, Germany, at the 5
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.